Literature DB >> 15042637

Alzheimer's disease caregiving information and skills, part III: group process issues and concerns.

Suzanne Perraud1, Carol J Farran, Dimitra Loukissa, Olimpia Paun.   

Abstract

In this descriptive study we examined content and processes in a group-based component of an ongoing clinical trial with family caregivers of persons with dementia. The purpose was to identify issues arising from the group processes that could be used to inform future skill-building caregiver groups. Summaries from two types of intervention groups, a caregiver skill-building (CSB) treatment intervention and an information and support only (ISO) control intervention were examined, along with data collected during a group leader debriefing session. Three major categories of process information were identified: (a) group member behaviors that support group processes necessary for skill development, (b) group leader behaviors that support group processes necessary for skill development, and (c) the phases of learning in caregiver (CG) skill development. Subcategories and specific content in each of these areas are identified in this article, and a list of member and leader behaviors that might support future skill development in groups is presented. Copyright 2004 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 15042637     DOI: 10.1002/nur.20013

Source DB:  PubMed          Journal:  Res Nurs Health        ISSN: 0160-6891            Impact factor:   2.228


  2 in total

1.  Descriptive study of partners' experiences of living with severe heart failure.

Authors:  Christopher C Imes; Cynthia M Dougherty; Gail Pyper; Mark D Sullivan
Journal:  Heart Lung       Date:  2011-03-16       Impact factor: 2.210

2.  Impact of Noncaregiving-Related Stressors on Informal Caregiver Outcomes.

Authors:  Mary Guerriero Austrom; Yvonne Yueh-Feng Lu; Anthony J Perkins; Malaz Boustani; Christopher M Callahan; Hugh C Hendrie
Journal:  Am J Alzheimers Dis Other Demen       Date:  2014-01-09       Impact factor: 2.035

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.